Spondylitis (2026): Types, Causes, Symptoms, Diagnosis & Treatment

A note before you read further: “Spondylitis” is not one disease. It is a word that gets applied to at least three very different problems: an inflammatory disease of the spine and sacroiliac joints, an infection of the vertebrae and discs, and, loosely and incorrectly, age-related wear of the spine. The right treatment depends entirely on which one you have. If you have back pain with fever, severe or rapidly worsening pain, new leg weakness, numbness in the groin or saddle area, or new bladder or bowel problems, seek urgent medical care now rather than reading further.

Spondylitis means inflammation of one or more vertebrae. The term is used for inflammatory disease (axial spondyloarthritis, which includes ankylosing spondylitis), for spinal infection (spondylodiscitis or vertebral osteomyelitis, including spinal tuberculosis), and, informally, for degenerative changes that are properly called spondylosis. Inflammatory spondylitis typically starts gradually before age 40, causes back pain and morning stiffness that improve with movement rather than rest, and is treated with exercise, NSAIDs, and sometimes biologic medicines. Infection needs urgent diagnosis and antimicrobial treatment. Degenerative spondylosis is managed differently again.

What “Spondylitis” Actually Means

The word comes from spondylos (vertebra) plus -itis (inflammation). In everyday use it is stretched to cover very different conditions, which is why a diagnosis of “spondylitis” on a report is only a starting point, not an answer.

Three situations account for most uses of the word:

If you were told you have “spondylitis,” the most useful first question is: inflammatory, infectious, or degenerative? Everything else follows from the answer.

Spondylitis vs. Spondylosis vs. Spondylolisthesis vs. Spondylolysis

These four words are one letter apart in some cases and mean completely different things.

Treating spondylosis as if it were inflammatory spondylitis, or the reverse, leads to the wrong medicines and the wrong expectations. Anti-inflammatory biologic drugs, for example, are for confirmed inflammatory disease, not for wear-and-tear. For degenerative problems, see our guides on spinal stenosis and disc herniation.

The Main Types of Spondylitis

Inflammatory (spondyloarthritis family)

Infectious

Inflammatory and infectious forms can look alike at first (back pain, raised inflammatory markers, abnormal MRI). Telling them apart is a core clinical task, and getting it wrong in either direction can cause harm.

Inflammatory Back Pain vs. Mechanical Back Pain

Inflammatory back pain tends to begin gradually, usually before age 40, with morning stiffness and night pain that improve with movement and do not improve with rest. Mechanical back pain usually does the opposite: it eases with rest and worsens with activity. These patterns are useful clues, but not proof either way.

Experts use these features as a framework for deciding who needs further assessment. They do not diagnose anyone on their own, and plenty of people with inflammatory disease have atypical patterns, while plenty with mechanical pain tick some of the boxes. If your symptoms fit the inflammatory column, that is a reason to see a rheumatologist, not a self-diagnosis.

Axial Spondyloarthritis and Ankylosing Spondylitis

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease mainly affecting the sacroiliac joints and spine. Ankylosing spondylitis is the form in which X-rays already show structural change at the sacroiliac joints. The non-radiographic form does not yet, but is part of the same disease spectrum.

• Where it starts: typically the sacroiliac joints (where the spine meets the pelvis), then potentially the spine
• What it does: inflammation at tendon and ligament attachments (entheses), which can heal with new bone formation. In some people, over years, this can link vertebrae together (fusion)
• Not everyone fuses. Many people with axSpA never develop significant spinal fusion, and treatment aims to control inflammation and protect function
• Who gets it: it is often described as a disease of young men, but women are affected too and are often diagnosed later, with diagnostic delay of years well documented in the literature
• Causes: not fully understood. Genetic susceptibility (notably HLA-B27) plays a major role, alongside other genes and environmental factors. It is not caused by posture, injury, or lifestyle, and it is not contagious

The terminology matters. Current practice treats axSpA as one disease spectrum, with “non-radiographic” and “radiographic” describing whether damage is visible on X-ray, not two unrelated conditions. Some people with the non-radiographic form progress to the radiographic form; many do not, and no reliable single percentage applies to everyone.

Symptoms and Extra-Spinal Features

Spinal and pelvic

• Gradual lower back and buttock pain, sometimes alternating sides
• Morning stiffness lasting longer than usual
• Night pain that eases after getting up and moving
• Pain and stiffness that improve with exercise
• Over time in some people, reduced spinal mobility and stooped posture

Beyond the spine (these matter for diagnosis and treatment choice)

These extra-spinal features are not side notes. They help diagnosis, and they influence medication choice (for example, which biologic is preferred when uveitis or IBD is present).

Red Flags and Emergencies

Different diagnoses carry different emergencies. They should not be blurred together.

Seek urgent same-day medical care for:

• Back pain with fever, chills, or feeling systemically unwell (possible spinal infection)
• New or rapidly progressive leg weakness or numbness
• New bladder or bowel dysfunction, or numbness in the groin or saddle area (possible cauda equina syndrome)
• A painful red eye with light sensitivity, particularly if you have known or suspected axSpA (possible uveitis, which can threaten vision if untreated)
• New neck or back pain after even minor trauma in someone with long-standing axSpA. A rigid, fused, often osteoporotic spine can fracture from low-energy injuries, and these fractures can be unstable and easily missed

Seek prompt (not necessarily emergency) assessment for:

• Severe pain that is progressively worsening or constant, including at rest
• Back pain with unexplained weight loss, night sweats, or a history of cancer
• Back pain if you are immunosuppressed, have diabetes, use injected drugs, or have had a recent spinal procedure or bloodstream infection

No single red flag proves a serious cause, and most people with back pain do not have one. But infection and fracture are conditions where delay causes harm, which is why this list exists.

Causes and Risk Factors

Inflammatory spondylitis

• Genetic susceptibility, including HLA-B27 (discussed below)
• Family history of spondyloarthritis, psoriasis, uveitis, or IBD
• Immune-mediated mechanisms, with gut involvement under study
• Smoking is associated with worse disease activity and progression
• Not caused by injury, posture, sports, or sitting

Infectious spondylitis

• Bacteria reaching the spine through the bloodstream from another source (skin, urinary tract, heart valves, dental or other infection)
• Direct spread after spinal surgery, injections, or procedures
• Risk factors include diabetes, immunosuppression, advanced age, chronic kidney or liver disease, injected drug use, and malnutrition
• TB spine usually reflects spread from TB elsewhere in the body, and is more common where TB is common

Degenerative spondylosis

• Ageing, genetics, mechanical load, smoking, and prior injury, as covered in our disc herniation and stenosis guides

How Inflammatory Spondylitis Is Diagnosed

Diagnosis relies on clinical history and examination, laboratory tests, and imaging, interpreted together by a clinician experienced in spondyloarthritis. No single test confirms or excludes it.

Clinicians commonly work from an internationally used classification framework (ASAS). In simplified terms:

• Evidence of sacroiliitis on imaging, plus at least one typical spondyloarthritis feature, or
• A positive HLA-B27 plus at least two typical features

Typical features include inflammatory back pain, arthritis, enthesitis, uveitis, dactylitis, psoriasis, IBD, a good response to NSAIDs, family history, HLA-B27, and raised CRP.

This is a classification framework used with clinical judgment, not a self-test. The practical steps are:

1. Detailed history, including inflammatory pattern, family history, eye, skin, and bowel history
2. Examination of spinal mobility, sacroiliac joints, entheses, and peripheral joints
3. Blood tests (CRP/ESR, HLA-B27 where appropriate, and other tests to exclude mimics)
4. Imaging: usually pelvic X-ray first, then MRI of the sacroiliac joints (and sometimes spine) when X-rays are normal but suspicion remains
5. Assessment for associated conditions (uveitis, psoriasis, IBD)

Diagnosis is often delayed, sometimes by years, partly because back pain is common and the inflammatory pattern is easy to miss. It is also sometimes over-diagnosed on the basis of an isolated MRI or HLA-B27 result. Both errors are real, which is why expert interpretation matters.

HLA-B27, CRP, and ESR: What They Can and Cannot Tell You

HLA-B27 is a genetic marker strongly associated with axial spondyloarthritis, but many people who carry it never develop the disease, and some people with axSpA do not carry it. CRP and ESR can be normal even when the disease is active. None of these tests can confirm or exclude the diagnosis alone.

Two practical consequences:

• A positive HLA-B27 does not mean you have, or will get, ankylosing spondylitis. Interpreted without symptoms or imaging, it can cause needless worry or even over-treatment.
• A normal CRP or negative HLA-B27 does not mean your back pain is “not inflammatory.” They lower, but do not remove, suspicion.

Markedly raised CRP and ESR with fever and severe pain should also prompt consideration of infection, not just inflammatory disease.

Imaging: Why a Normal X-Ray Does Not Settle the Question

Sacroiliac changes can take years to appear on X-ray. A normal X-ray therefore does not exclude axial spondyloarthritis. MRI can show active inflammation earlier, but MRI findings also need careful interpretation, because similar changes can occur in people without the disease.

An MRI report saying “sacroiliitis” is not automatically a diagnosis of spondyloarthritis, and a normal X-ray is not an all-clear. The combination of symptoms, examination, labs, and imaging is what counts.

What Can Mimic Inflammatory Spondylitis

Because fibromyalgia and axSpA can coexist, and because treatment failure often reflects a wrong or partial diagnosis, current European guidance explicitly advises re-evaluating the diagnosis when treatment does not work.

Spinal Infection (Infectious Spondylitis)

Spinal infection is a potentially serious condition that needs urgent diagnosis, identification of the organism, and prolonged targeted antimicrobial treatment. It must not be mistaken for inflammatory or mechanical back pain, and it should never be treated at home or with steroids on suspicion alone.

Warning features: back pain that is severe, progressive, or present at rest; fever or chills (though fever is absent in some patients); tenderness over the spine; and risk factors such as diabetes, immunosuppression, injected drug use, recent spinal surgery or injection, or a known source of infection elsewhere. Neurological symptoms (weakness, numbness, bladder or bowel changes) suggest abscess or cord or nerve compression and are emergencies.

Diagnosis

• MRI of the spine, usually with contrast, is the key imaging test
• Blood tests: CRP and ESR are usually raised; blood cultures are important, ideally before antibiotics when the patient is stable
• Biopsy (image-guided or surgical) to identify the organism when blood cultures do not, which matters because treatment depends on the organism
• Additional testing for TB, brucellosis, or fungal causes where relevant to the region and risk profile

Treatment principles

• Treatment is directed at the organism, with antibiotics for bacterial infection and prolonged multi-drug anti-tuberculosis therapy for spinal TB
• For microbiologically confirmed pyogenic vertebral osteomyelitis, a randomized trial of about 359 patients (Bernard et al., Lancet, 2015) found 6 weeks of antibiotics non-inferior to 12 weeks. Longer courses may still be needed for resistant organisms, abscess, or extensive bone destruction. Duration is individualized and set by the treating team
• Spinal TB treatment is also prolonged and individualized; regimens and duration are set by TB or infectious disease specialists, and self-medication or stopping early can cause drug resistance
• Surgery is used selectively: neurological deficit or cord compression, large abscess, spinal instability or deformity, or failure of medical treatment. Many patients are treated without surgery
• Immobilization and pain control support recovery, but these are adjuncts, not the treatment

An important safety point: medicines that suppress immunity (steroids, and biologics used for inflammatory spondylitis) can worsen infection. This is one reason an accurate diagnosis comes before treatment, and why screening for TB and hepatitis is standard before starting biologics.

“Cervical Spondylitis” and Degenerative Spondylosis

When people say “cervical spondylitis,” they most often mean cervical spondylosis, which is age-related degeneration of the neck’s discs and joints. It is not inflammatory disease, and anti-inflammatory biologic therapy is not its treatment.

• Cervical spondylosis commonly causes neck stiffness and pain, and sometimes radiating arm symptoms (radiculopathy)
• Less commonly, narrowing of the spinal canal presses on the spinal cord (cervical myelopathy), causing hand clumsiness, balance or walking changes, and sometimes bladder or bowel changes. These need prompt specialist assessment
• True inflammatory involvement of the neck occurs in axSpA, and in advanced disease can cause stiffness and forward-flexed neck posture, but it is a different problem from spondylosis
• Imaging evidence of degeneration is very common with age and often does not match symptoms, as discussed in our disc herniation and spinal stenosis guides

If your report says “spondylitis” but describes disc bulges, osteophytes, and narrowing, ask your doctor whether this is degenerative spondylosis, since the management is different.

Treatment of Inflammatory Spondylitis

The treatment goals are to control inflammation, relieve pain and stiffness, preserve mobility and function, and where possible slow structural damage. The backbone of treatment is education, regular exercise, NSAIDs, and, for those who need it, biologic or targeted synthetic DMARDs, guided by a rheumatologist.

The 2022 ASAS-EULAR recommendations and updated 2026 ACR guidance broadly agree:

1. Education, exercise, and stopping smoking are core, not optional extras
2. NSAIDs are first-line drug treatment for most people, with the lowest effective dose and attention to stomach, kidney, and cardiovascular risks
3. If disease remains active despite adequate NSAID trials (the European guidance defines this as at least two NSAIDs and a persistently high disease activity score, with objective evidence of inflammation), a biologic or targeted synthetic DMARD is considered
4. TNF inhibitors and IL-17 inhibitors are the usual first biologic choices, with JAK inhibitors an option but not first-line in the updated ACR guidance
5. If treatment fails, re-evaluate the diagnosis and look for comorbidity before simply switching drugs
6. In sustained remission, tapering (not abrupt stopping) of a biologic can be considered
7. Conventional DMARDs and systemic steroids have limited or no role for purely axial disease. Sulfasalazine can be considered for peripheral arthritis, and local steroid injection can help individual swollen joints or entheses

Treatment is guided by disease-activity scores (such as ASDAS), symptoms, inflammation markers, and imaging, not by pain alone.

Medications in Detail

This section describes medication categories for education. It does not prescribe or give doses.

Key safety and practical points:

• Screening before biologics typically includes tests for latent or active TB and for hepatitis B and C. This is especially important in regions where TB is common
• Biologics raise infection risk, and you should seek medical advice early for fever or persistent infection
• Vaccination planning is usually done before starting treatment
• Pregnancy and breastfeeding need planning in advance; do not stop or start medication on your own
• Approval status and availability differ by country. For example, bimekizumab is FDA-approved for active ankylosing spondylitis and non-radiographic axSpA; other regulators may differ. Biosimilar versions of some TNF inhibitors are available in many countries, which can change cost
• No biologic is “best for everyone.” Choice depends on your extra-spinal features, other conditions, prior treatments, safety profile, access, and cost

Exercise and Physiotherapy, With Precautions

Regular, appropriate exercise is a core treatment for inflammatory spondylitis. It helps pain, stiffness, posture, and function. But exercise advice has to be adapted to the diagnosis and the stage, because what is good for axSpA can be unsafe in infection, acute fracture, or advanced osteoporosis.

Generally beneficial in inflammatory spondylitis (under physiotherapist guidance where possible):

• Daily mobility and stretching, with emphasis on spinal extension, chest expansion, and hip mobility
• Posture work
• Aerobic activity such as walking, swimming, or cycling
• Strengthening for the back, core, and hips
• Breathing exercises, since chest-wall stiffness can occur

Precautions that matter:

• Do not exercise through suspected infection, severe unexplained spinal pain with fever, or new neurological symptoms. Get assessed first
• If you have a long-standing, stiff spine, avoid forceful manipulation, high-impact activity, and contact sports where falls are likely, because the spine can fracture under low forces, particularly with osteoporosis
• Be cautious with spinal manipulation (including neck manipulation) in established axSpA, advanced disease, or suspected osteoporosis, since fracture and neurological injury are possible
• Be cautious with aggressive yoga or deep forceful stretching in a fused or osteoporotic spine. Gentle, supervised practice is different from forced end-range positions
• After any fall or minor trauma with new pain, seek assessment rather than assuming it is “just a flare”
• Exercise helps symptoms and function; it does not replace medication in active, high-disease-activity disease

For infection, activity is guided by the treating team and usually involves rest and protection of the spine early on, then gradual rehabilitation.

Surgery: When It Is and Is Not Relevant

Surgery is not a treatment for inflammatory spondylitis itself. It is relevant only for specific complications:

Because surgery is chosen by diagnosis, a surgical recommendation without a clear diagnosis should prompt a second opinion.

Living With Spondylitis: Pregnancy, Bones, Eyes, Work

• Pregnancy: many people with axSpA have healthy pregnancies. Planning ahead with both rheumatology and obstetrics matters, because medicine choices differ in pregnancy and breastfeeding
• Bone health: osteoporosis and spinal fractures are recognized in longer-standing disease. Bone density assessment and attention to vitamin D, calcium, and fall prevention are part of long-term care
• Eyes: recurrent acute anterior uveitis is common enough that prompt eye care is part of the plan
• Heart and lungs: uncommon complications can occur; your team will advise on monitoring
• Fatigue and mental health: both deserve attention and can be improved by treatment and support
• Work and daily life: most people continue working, often with adjustments such as movement breaks and ergonomic changes
• Children and adolescents: juvenile spondyloarthritis is managed in paediatric rheumatology, and the ACR released a dedicated companion guideline for juvenile axSpA

Prognosis

Outcomes vary widely. Many people with axial spondyloarthritis, with early recognition and appropriate treatment, maintain good function and quality of life. Untreated or undertreated active disease can lead to progressive stiffness and structural damage in some people.

What shapes the outlook:

• How early the diagnosis is made and treatment starts
• Disease activity and how well it is controlled
• Smoking status
• Extra-spinal involvement
• Whether structural damage has already occurred
• Adherence to exercise and treatment

No reliable single survival, progression, or remission percentage applies to every patient, so we have not quoted one. For spinal infection, outcomes depend heavily on how early it is diagnosed and treated, the organism, and whether neurological deficit is present before treatment.

Spondylitis Care in India and Cost

India has rheumatology, spine surgery, infectious disease, and imaging services across many cities, and spinal TB is a condition clinicians in India see more often than clinicians in many other countries. But capability varies by hospital, and cost depends heavily on the diagnosis.

Because “spondylitis” covers very different conditions, the care pathway differs:

• Inflammatory axSpA: care is mostly outpatient and long-term, with a rheumatologist, physiotherapy, imaging, blood tests, and, where needed, biologic therapy. The largest cost driver over time is the medicine, and biosimilar availability and local pricing can change this considerably
• Spinal infection: may involve hospital admission, MRI, biopsy, intravenous antibiotics or prolonged anti-TB therapy, and sometimes surgery
• Degenerative spondylosis: see our spinal stenosis and disc herniation guides

On cost: we did not verify current India-specific prices for rheumatology consultation, MRI, biologics, infection admission, or spinal surgery with enough confidence to publish figures, so we have not given any. Costs depend on the diagnosis, investigations, medicines (especially biologics, whose price differs by drug, brand, and biosimilar availability), hospital and room category, length of stay, surgery and implants if any, and follow-up. A written estimate based on your actual reports and plan is the only reliable number.

We are not claiming India is superior to care available at home, and we have not named hospitals, rankings, success rates, or capabilities. For inflammatory axSpA, long-term follow-up usually happens close to home, so travel is mostly relevant for second opinions, diagnostic clarification, or specific procedures.

International Patient Journey and Travel Safety

1. Share your reports: symptoms timeline, X-rays, MRI images (not just reports), blood tests (CRP, ESR, HLA-B27 if done), eye, skin, and bowel history, current medicines, and prior treatment
2. Preliminary specialist review to clarify the likely diagnosis (inflammatory, infectious, degenerative, or mixed) and whether travel is needed at all
3. Decide whether an in-person assessment, additional imaging, or a biopsy is actually required
4. Treatment options and written cost estimate for the specific plan
5. Medical visa documentation and travel planning
6. In-person consultation, any required tests, and treatment if recommended
7. Rehabilitation planning and a clear handover for your local doctors, which matters especially for long-term disease such as axSpA

Do not delay local care to arrange travel if you have fever with spinal pain, progressive weakness, numbness in the saddle area, bladder or bowel changes, a painful red eye with light sensitivity, or new pain after trauma with a long-standing stiff spine. These need urgent local assessment. Travel should be considered only when you are stable.

Shifam Health is a healthcare coordination and international patient support service, not a hospital, treating doctor, or diagnostic authority. It can help organize records, coordinate specialist opinions, communicate with hospitals, obtain estimates, support visa documentation, and arrange travel and local logistics. It does not diagnose, choose treatment, or guarantee outcomes, recovery, costs, or visa approval. Medical decisions stay with your treating clinicians.

Second Opinion and Questions to Ask

Consider a second opinion if:

• You have been told you have “spondylitis” without it being specified whether it is inflammatory, infectious, or degenerative
• Biologic therapy is being recommended on the strength of an MRI or HLA-B27 alone
• Treatment has not worked and the diagnosis has not been revisited
• Surgery is proposed without a clear diagnosis
• Symptoms and imaging do not fit together
• Infection is suspected but no organism has been identified

Bring: MRI images and reports, X-rays, all blood test results, medication and injection history, and a summary of other symptoms (eyes, skin, bowels, family history).

Questions to ask your specialist

• Is my spondylitis inflammatory, infectious, or degenerative, and how do you know?
• Do I meet criteria for axial spondyloarthritis, and which type?
• What does my HLA-B27 or CRP result actually mean for me?
• Could my back pain have another cause, such as mechanical pain or fibromyalgia, alongside or instead?
• Do I need an MRI of the sacroiliac joints or spine?
• Have infection and TB been considered, and screened for where relevant?
• Which NSAIDs have I tried, at what dose and for how long?
• If a biologic is suggested, why that class, and what screening is needed first?
• What are the risks of this medicine for me specifically?
• What exercise is safe for me, and what should I avoid?
• Do I need a bone density scan?
• What symptoms should make me contact you urgently?
• What is the plan if this treatment does not work?

Decision Framework

This table is educational, not individualized medical advice.

Myths vs. Facts

Frequently Asked Questions